- Published on
CDSCO Manufacturing License for Radionuclide rebreathing system
- Authors
- Name
- CDSCO Licenses Blog
Introduction
The Central Drugs Standard Control Organization (CDSCO) is an essential pillar of India's healthcare sector. It is endowed with the responsibility of ensuring the safety, efficacy, and quality standards of drugs, cosmetics, diagnostics, and medical devices. In the realm of medical devices, its role is pivotal. It obliges manufacturers to obtain licenses before starting production - a strategic initiative undertaken to safeguard consumer health and medical efficacy.
Medical devices, in general, play a critical role in diagnosing, preventing, monitoring, and treating health conditions. One such medical device termed as 'Radionuclide Rebreathing System,' significantly influences the medical patio in Radiology. This blog aims to shed light on the essence of the Radionuclide Rebreathing System and the criticalities associated with obtaining a manufacturing license for the same. For further information on CDSCO and its functions, you may refer to CDSCO's official portal.
- What is a Radionuclide Rebreathing System?
- The Role of CDSCO in Medical Device Regulation
- How to Manufacture a Radionuclide Rebreathing System
- Fees for Manufacturing License for Radionuclide Rebreathing System
- Why is a Manufacturing License Necessary for a Radionuclide Rebreathing System?
- Steps to Obtain a CDSCO Manufacturing License for a Radionuclide Rebreathing System
- Frequently Asked Questions (FAQs)
- Conclusion
What is a Radionuclide Rebreathing System?
A Radionuclide Rebreathing System is a medical device that plays an essential role in nuclear medicine. It is designed to contain a gaseous or volatile radionuclide or a radionuclide-labeled aerosol, allowing a patient to respire it during nuclear medicine ventilatory tests. These tests are performed to understand the exchange process between the lungs and the atmosphere, subsequently aiding in the diagnosis of various diseases.
The Role of CDSCO in Medical Device Regulation
The CDSCO has, over the years, established stringent regulations in place to govern the manufacturing and utilization of medical devices. Given its mission to safeguard public health in India, CDSCO undertakes the task of evaluating and ensuring the standard functioning of medical devices such as the Radionuclide Rebreathing System.
How to Manufacture a Radionuclide Rebreathing System
Procuring a Class C license for manufacturing a Radionuclide Rebreathing System involves several prerequisites, including submission of crucial documents such as the Device Master File, Quality Management Certificate, Device Details, Site details, etc.
Fees for Manufacturing License for Radionuclide Rebreathing System
For securing a Class C license for the manufacture of a Radionuclide Rebreathing System, an entity needs to spend Rs. 50,000 as license fees, along with Rs. 1,000 per product.
Why is a Manufacturing License Necessary for a Radionuclide Rebreathing System?
It is mandatory for manufacturers to obtain a manufacturing license for Radionuclide Rebreathing Systems. This enactment orders to ensure quality production and safety in medical devices, meet the regulatory compliance required in the healthcare sector, and protect consumers and patients from potentially harmful, substandard products.
Steps to Obtain a CDSCO Manufacturing License for a Radionuclide Rebreathing System
- Necessary prerequisites and documentation are required.
- Application process: From submission to approval
- Overcoming common challenges in the process.
Follow this link to understand more about the license requirement for Class C devices: CDSCO MD9 License Information
Frequently Asked Questions (FAQs)
Q1. What is the risk class of a Radionuclide Rebreathing System as per Medical Device Rules, 2017? The Radionuclide Rebreathing System falls under Risk Class C.
Q2. What license is needed to manufacture a Radionuclide Rebreathing System? An MD9 license is needed to manufacture a Radionuclide Rebreathing System.
Q3. What is the fee for an MD9 license for a Radionuclide Rebreathing System? The fee for an MD9 license is Rs. 50,000, along with Rs. 1,000 per device.
Q4. Who will issue a manufacturing license for a Radionuclide Rebreathing System? The CDSCO HQ in New Delhi will issue the license for Class C devices like the Radionuclide Rebreathing System.
Q5. Is repackaging of a Radionuclide Rebreathing System considered manufacturing? Yes, as per the Drugs and Cosmetics Act's definition, repackaging of drugs is considered manufacturing. By extension, medical devices, including Radionuclide Rebreathing Systems, when repackaged, also require an MD9 license.
Conclusion
It is crucial to understand the dynamics of obtaining a manufacturing license for medical devices in India. If you require assistance or would like to consult regarding the licensing process, feel free to reach out to the Pharmadocx Consultants or call at +91-7404557227 or email to [email protected] for further support.
